Tag: Fate Therapeutics Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Fate Therapeutics Inc

Equities Analysts Issue Forecasts for Fate Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:FATE)

Added to Collection on: 2021-06-08 09:56:01

Tags for this article:

Finance
Financial markets
Money
Corporate finance
Stock
Stock market
NASDAQ
Price?earnings ratio
Fate Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics to Host Virtual Event Highlighting Interim Phase 1 Clinical Data from its Off-the ...

Added to Collection on: 2021-07-16 12:00:00

Tags for this article:

Branches of biology
Clinical medicine
Medicine
Immune system
Cancer immunotherapy
Biotechnology
Clusters of differentiation
Specialty drugs
Antibody-dependent cellular cytotoxicity
CD16
Immunotherapy
Natural killer cell
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Dowling & Yahnke Llc Buys Vanguard S&P 500 ETF, Fate Therapeutics Inc, MicroStrategy Inc ...

Added to Collection on: 2021-07-21 17:37:30

Tags for this article:

Finance
Financial markets
Exchange-traded funds
Money
Stock market
S&P Global
SPDR
Stock
IShares
Berkshire Hathaway
Microstrategy Inc
Fate Therapeutics Inc
Taiwan Semiconductor Manufacturing Co Ltd
Lumen Technologies Inc
New Mountain Finance Corp.

Click the tags to see associated articles and topics

View Article Details
Gets Its Catalyst And Trades Up: Fate Therapeutics Inc. (FATE), Vor Biopharma Inc. (VOR)

Added to Collection on: 2021-07-24 17:15:00

Tags for this article:

Stock market
Finance
Financial economics
Money
Stock
Relative strength index
Investment
Share price
Financial market
assenagon asset management s.a.
Fate Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational ...

Added to Collection on: 2021-08-04 19:52:30

Tags for this article:

Branches of biology
Clinical medicine
Medicine
Immune system
Cancer immunotherapy
Orphan drugs
Biotechnology
Chimeric antigen receptor T cell
Natural killer cell
Daratumumab
Leukemia
Immunotherapy
Fate Therapeutics Inc
Rituximab
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Lisanti Capital Growth, LLC Buys Asana Inc, Lattice Semiconductor Corp, Brooks ... - GuruFocus

Added to Collection on: 2021-08-24 16:30:00

Tags for this article:

Financial economics
Finance
Money
Corporate finance
Stock
Stock market
Share trading
Financial markets
Brooks Automation Inc
Lattice Semiconductor Corp
Inspire Medical Systems Inc
Fate Therapeutics Inc
Revolve Group Inc.
Allegiant Travel Co
Oshkosh Corp
Halozyme Therapeutics Inc.
Pacira Biosciences Inc
Lisanti Capital Growth LLC

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics to Host Virtual Event at the 2021 ASH Annual Meeting | Your Money | kulr8.com

Added to Collection on: 2021-12-09 05:12:01

Tags for this article:

Branches of biology
Clinical medicine
Medicine
Immune system
Cancer immunotherapy
Clusters of differentiation
Lymphoma
Biotechnology
Antibody-dependent cellular cytotoxicity
Immunotherapy
Natural killer cell
CD16
Fate Therapeutics Inc
SAN DIEGO

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights

Added to Collection on: 2022-03-01 03:12:37

Tags for this article:

Medical specialties
Branches of biology
Clinical medicine
Immune system
Cancer immunotherapy
Lymphoma
Clusters of differentiation
Lymphocytes
Natural killer cell
Chimeric antigen receptor T cell
Daratumumab
Antibody-dependent cellular cytotoxicity
Fate Therapeutics Inc
Rituximab

Click the tags to see associated articles and topics

View Article Details
Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress

Added to Collection on: 2022-05-04 20:08:35

Tags for this article:

Branches of biology
Clinical medicine
Medicine
Immune system
Cancer immunotherapy
Lymphocytes
Biotechnology
Natural killer cell
Chimeric antigen receptor T cell
Immunotherapy
Antibody-dependent cellular cytotoxicity
CD16
Fate Therapeutics Inc
Rituximab

Click the tags to see associated articles and topics

View Article Details
Contrasting Fate Therapeutics (NASDAQ:FATE) & Ambrx Biopharma (NYSE:AMAM)

Added to Collection on: 2022-07-21 17:52:21

Tags for this article:

Life Sciences
Companies
Industry economics)
Bristol-Myers Squibb
AbbVie
AIM ImmunoTech
Celgene
Ambrx Biopharma Inc.
Fate Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details